HK1179889A1 - 抗體及其用途 - Google Patents

抗體及其用途

Info

Publication number
HK1179889A1
HK1179889A1 HK13107325.6A HK13107325A HK1179889A1 HK 1179889 A1 HK1179889 A1 HK 1179889A1 HK 13107325 A HK13107325 A HK 13107325A HK 1179889 A1 HK1179889 A1 HK 1179889A1
Authority
HK
Hong Kong
Prior art keywords
gep
antibody
gep antibody
Prior art date
Application number
HK13107325.6A
Other languages
English (en)
Inventor
張兆恬
范上達
Original Assignee
香港大學
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 香港大學 filed Critical 香港大學
Publication of HK1179889A1 publication Critical patent/HK1179889A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
HK13107325.6A 2010-05-14 2013-06-24 抗體及其用途 HK1179889A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33467110P 2010-05-14 2010-05-14
PCT/CN2011/000834 WO2011140828A1 (en) 2010-05-14 2011-05-13 Gep antibody and uses thereof

Publications (1)

Publication Number Publication Date
HK1179889A1 true HK1179889A1 (zh) 2013-10-11

Family

ID=44911978

Family Applications (1)

Application Number Title Priority Date Filing Date
HK13107325.6A HK1179889A1 (zh) 2010-05-14 2013-06-24 抗體及其用途

Country Status (5)

Country Link
US (1) US20110280862A1 (zh)
EP (1) EP2569011A4 (zh)
CN (1) CN102985111B (zh)
HK (1) HK1179889A1 (zh)
WO (1) WO2011140828A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
EP2752487A1 (en) * 2013-01-03 2014-07-09 Sanofi Intracellular phenotypic screening
EP3003371B1 (en) * 2013-05-30 2022-05-25 The University of Hong Kong Materials and methods for treatment of liver cancer background of the invention
US20230136997A1 (en) * 2020-04-15 2023-05-04 Children's Medical Center Corporation Targeting abcb5 in glioblastoma multiforme
EP4384276A1 (en) * 2021-08-10 2024-06-19 Apexigen, Inc. Biomarkers for cd40 agonist therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060058311A1 (en) * 2004-08-14 2006-03-16 Boehringer Ingelheim International Gmbh Combinations for the treatment of diseases involving cell proliferation
WO2008064570A1 (en) * 2006-11-28 2008-06-05 The University Of Hong Kong The use of granulin-epithelin precursor (gep) antibodies for detection and suppression of hepatocellular carcinoma (hcc)
SI2644205T1 (sl) * 2007-04-12 2018-11-30 The Brigham And Women's Hospital, Inc. Ciljanje ABCB5 za zdravljenje raka

Also Published As

Publication number Publication date
EP2569011A4 (en) 2013-06-12
EP2569011A1 (en) 2013-03-20
WO2011140828A1 (en) 2011-11-17
CN102985111B (zh) 2014-05-07
CN102985111A (zh) 2013-03-20
US20110280862A1 (en) 2011-11-17

Similar Documents

Publication Publication Date Title
HUS2100034I1 (hu) ANGPTL3-ellenes antitestek és alkalmazásaik
IL288203B (en) Meditops and Meditop binding antibodies and their use
IL232399A0 (en) Anti-2fgfr antibodies and their use
SI2946791T1 (sl) Protitelesa proti CD277 in uporabe le-teh
IL225484A0 (en) Anti-48cd antibodies and their uses
EP2756094A4 (en) ANTI-B7-H4 ANTIBODIES AND USES THEREOF
EP2794654A4 (en) ANTI-PHF-TAU ANTIBODIES AND ITS USES
HK1179981A1 (zh) 的抗體及其用途
PL2361936T3 (pl) Cząsteczka wiążąca antygen i jej zastosowania
EP2632952A4 (en) ANTI-SOD1 ANTIBODIES AND USES THEREOF
HK1199842A1 (zh) 抗涎免凝集素- 抗體及其用途
EP2593475A4 (en) ANTI-ADDL MONOCLONAL ANTIBODY AND USES THEREOF
EP2621955A4 (en) ANTI-CEACAM6 ANTIBODIES AND USES THEREOF
EP2608785A4 (en) LIPOMA CYCLES AND ITS USES
HK1179889A1 (zh) 抗體及其用途
EP2554552A4 (en) NOVEL ANTI-CD98 ANTIBODIES AND USE THEREOF
EP2529013A4 (en) NOVEL BETA GLUCOSIDASE AND USES THEREOF
EP2620449A4 (en) EPIDINATED ANTIBODIES AGAINST B2 AND THE USE THEREOF
EP2545378A4 (en) ANTI-LG3 ANTIBODIES AND USES THEREOF
EP2578682A4 (en) ANTIBODIES AND ITS USE